Wells Fargo’s Eton Pharmaceutcials ETON Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $196K | Buy |
13,750
+13,000
| +1,733% | +$185K | ﹤0.01% | 4398 |
|
2025
Q1 | $9.74K | Sell |
750
-250
| -25% | -$3.25K | ﹤0.01% | 5425 |
|
2024
Q4 | $13.3K | Buy |
+1,000
| New | +$13.3K | ﹤0.01% | 5370 |
|
2024
Q2 | – | Sell |
-1,425
| Closed | -$5.34K | – | 6640 |
|
2024
Q1 | $5.34K | Buy |
1,425
+1,253
| +728% | +$4.7K | ﹤0.01% | 5492 |
|
2023
Q4 | $753 | Buy |
172
+9
| +6% | +$39 | ﹤0.01% | 5851 |
|
2023
Q3 | $680 | Buy |
163
+11
| +7% | +$46 | ﹤0.01% | 5917 |
|
2023
Q2 | $530 | Buy |
152
+7
| +5% | +$24 | ﹤0.01% | 6166 |
|
2023
Q1 | $558 | Sell |
145
-3,998
| -97% | -$15.4K | ﹤0.01% | 6205 |
|
2022
Q4 | $11.7K | Buy |
4,143
+4
| +0.1% | +$11 | ﹤0.01% | 5165 |
|
2022
Q3 | $9K | Buy |
4,139
+1
| +0% | +$2 | ﹤0.01% | 5388 |
|
2022
Q2 | $11K | Sell |
4,138
-3,486
| -46% | -$9.27K | ﹤0.01% | 5411 |
|
2022
Q1 | $34K | Buy |
7,624
+7,500
| +6,048% | +$33.4K | ﹤0.01% | 5477 |
|
2021
Q4 | $1K | Buy |
124
+1
| +0.8% | +$8 | ﹤0.01% | 6438 |
|
2021
Q3 | $1K | Sell |
123
-316
| -72% | -$2.57K | ﹤0.01% | 6360 |
|
2021
Q2 | $3K | Sell |
439
-15,912
| -97% | -$109K | ﹤0.01% | 6116 |
|
2021
Q1 | $120K | Sell |
16,351
-9,718
| -37% | -$71.3K | ﹤0.01% | 5071 |
|
2020
Q4 | $212K | Buy |
26,069
+5,548
| +27% | +$45.1K | ﹤0.01% | 4927 |
|
2020
Q3 | $162K | Sell |
20,521
-8,592
| -30% | -$67.8K | ﹤0.01% | 4884 |
|
2020
Q2 | $158K | Buy |
29,113
+26,040
| +847% | +$141K | ﹤0.01% | 4846 |
|
2020
Q1 | $12K | Sell |
3,073
-2,927
| -49% | -$11.4K | ﹤0.01% | 5434 |
|
2019
Q4 | $43K | Hold |
6,000
| – | – | ﹤0.01% | 5290 |
|
2019
Q3 | $38K | Hold |
6,000
| – | – | ﹤0.01% | 5331 |
|
2019
Q2 | $47K | Hold |
6,000
| – | – | ﹤0.01% | 5279 |
|
2019
Q1 | $48K | Hold |
6,000
| – | – | ﹤0.01% | 5236 |
|
2018
Q4 | $37K | Buy |
+6,000
| New | +$37K | ﹤0.01% | 5304 |
|